FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W36360916> ?p ?o ?g. }

• W36360916 endingPage "8" @default.
• W36360916 startingPage "73" @default.
• W36360916 abstract "Breast cancer remains one of women's greatest concerns. When asked regarding the likelihood of contracting a specific disease, most women believe their greatest risk of death is from breast cancer. Interestingly, we have gone from a time when estrogen was utilized as a treatment regimen in advanced breast cancer, to the current question of hormone replacement therapy increasing the risk of breast cancer. When one searches earlier data, it is noted that estrogen in several different forms, including ethinyl estradiol, as well as DES, was used as a therapeutic agent in the management of advanced breast cancer. Indeed, some of the original trials evaluating tamoxifen for adjunctive treatment of breast cancer used estrogen as the gold-standard treatment arm. Numerous publications have attempted to address the relationship between hormone replacement therapy and breast cancer. In the last quarter of a century, at least 50 epidemiological studies have been published, with some studies demonstrating slight increases in patients who used hormone replacement therapy for an extended time, while others demonstrated no evidence of a change in incidence. The Nurses' Health Study suggested that current users of hormone replacement therapy of 5 or more years' duration have a relative risk of greater than 1.4. While a well-performed and conceived trial, it suffers from limitations like all other studies. In the same time period, multiple additional studies have cast doubt on the likelihood of hormone replacement therapy markedly increasing the risk of breast cancer. When the multitude of studies is combined, the evidence seems to demonstrate that in ever-use of hormone replacement therapy the increase in relative risk is small. It is interesting that, in almost all studies published (even those demonstrating increases such as the Nurses' Health Study) discontinuation of 2 to 5 years evaporates the increased risk. This seems biologically implausible, given the prior exposure. A recent study by Sellers et al evaluated over 41,000 patients in a prospective cohort. In this study, they closely evaluated patients who were at a higher risk of breast cancer based on a positive family history in first-degree relatives. Interestingly, they, like others, found that HRT was not associated with a significantly increased incidence of breast cancer, but did note a significantly reduced total mortality rate. When one evaluates the sum total data in the world literature regarding hormone replacement therapy and breast cancer, it is difficult to ascertain that any substantial clinical risk exists with the use of hormone replacement therapy and breast cancer. Multiple ongoing trials, including the Women's Health Initiative-a Prospective Protocol, will help to define better if any appreciable risk exists." @default.
• W36360916 created "2016-06-24" @default.
• W36360916 creator A5070716778 @default.
• W36360916 creator A5075164011 @default.
• W36360916 date "2001-05-26" @default.
• W36360916 modified "2023-09-23" @default.
• W36360916 title "Breast cancer and HRT--what are the data?" @default.
• W36360916 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11374658" @default.
• W36360916 hasPublicationYear "2001" @default.
• W36360916 type Work @default.
• W36360916 sameAs 36360916 @default.
• W36360916 citedByCount "1" @default.
• W36360916 crossrefType "journal-article" @default.
• W36360916 hasAuthorship W36360916A5070716778 @default.
• W36360916 hasAuthorship W36360916A5075164011 @default.
• W36360916 hasConcept C107130276 @default.
• W36360916 hasConcept C121608353 @default.
• W36360916 hasConcept C126322002 @default.
• W36360916 hasConcept C143998085 @default.
• W36360916 hasConcept C2777164284 @default.
• W36360916 hasConcept C2777176818 @default.
• W36360916 hasConcept C2779134260 @default.
• W36360916 hasConcept C2779279991 @default.
• W36360916 hasConcept C2780159708 @default.
• W36360916 hasConcept C2780275930 @default.
• W36360916 hasConcept C2781413609 @default.
• W36360916 hasConcept C29456083 @default.
• W36360916 hasConcept C530470458 @default.
• W36360916 hasConcept C535046627 @default.
• W36360916 hasConcept C71924100 @default.
• W36360916 hasConceptScore W36360916C107130276 @default.
• W36360916 hasConceptScore W36360916C121608353 @default.
• W36360916 hasConceptScore W36360916C126322002 @default.
• W36360916 hasConceptScore W36360916C143998085 @default.
• W36360916 hasConceptScore W36360916C2777164284 @default.
• W36360916 hasConceptScore W36360916C2777176818 @default.
• W36360916 hasConceptScore W36360916C2779134260 @default.
• W36360916 hasConceptScore W36360916C2779279991 @default.
• W36360916 hasConceptScore W36360916C2780159708 @default.
• W36360916 hasConceptScore W36360916C2780275930 @default.
• W36360916 hasConceptScore W36360916C2781413609 @default.
• W36360916 hasConceptScore W36360916C29456083 @default.
• W36360916 hasConceptScore W36360916C530470458 @default.
• W36360916 hasConceptScore W36360916C535046627 @default.
• W36360916 hasConceptScore W36360916C71924100 @default.
• W36360916 hasIssue "2" @default.
• W36360916 hasLocation W363609161 @default.
• W36360916 hasOpenAccess W36360916 @default.
• W36360916 hasPrimaryLocation W363609161 @default.
• W36360916 hasRelatedWork W177103438 @default.
• W36360916 hasRelatedWork W1979053388 @default.
• W36360916 hasRelatedWork W1998776036 @default.
• W36360916 hasRelatedWork W2045823922 @default.
• W36360916 hasRelatedWork W2121740447 @default.
• W36360916 hasRelatedWork W2141798191 @default.
• W36360916 hasRelatedWork W2177788881 @default.
• W36360916 hasRelatedWork W2998725311 @default.
• W36360916 hasRelatedWork W4210562535 @default.
• W36360916 hasRelatedWork W4246998335 @default.
• W36360916 hasVolume "46" @default.
• W36360916 isParatext "false" @default.
• W36360916 isRetracted "false" @default.
• W36360916 magId "36360916" @default.
• W36360916 workType "article" @default.